For example, ~2 U of insulin was sufficient to treat Alzheimer disease in rats, while in clinical testing, 10–20 U of insulin gave promising results (clinical trial ID: NCT01547169 for Phase II and NCT01767909 for Phase II/III)57. The gene discussed is INS; the disease is Alzheimer disease.